Fisiopatología y pronóstico de la deformación longitudinal regional durante el eco estrés con dipiridamol / Pathophysiology and Prognosis of Apical Longitudinal Strain During Dipyridamole Stress Echocardiography

RESUMEN Introducción: El strain longitudinal apical regional permite corroborar el diagnóstico de alteraciones regionales de la motilidad parietal sobre una base cuantitativa, pero faltan datos sobre su valor pronóstico a largo plazo. Objetivos: Evaluar el correlato fisiológico y el valor pronóstico del strain longitudinal apical en el eco estrés con dipiridamol frente a la motilidad parietal. Métodos: Estudio retrospectivo, que incluyó 150 pacientes remitidos para eco estrés con dipiridamol. Se evaluó el strain longitudinal apical, la reserva coronaria (RC) de la arteria descendente anterior y el análisis visual de la motilidad parietal. Los pacientes se dividieron en dos grupos. Grupo1: pacientes con strain longitudinal apical normal y Grupo 2: con strain anormal. Se realizó seguimiento por 36 ± 9,3 meses. Evento mayor fue definido como: muerte, infarto de miocardio, revascularización e internación por causa cardíaca. Resultados: Fueron incluidos en el análisis 142 pacientes (8 pacientes fueron excluidos por ventana ultrasónica subóptima), 87 (61,3%) en el Grupo 1 y 55 (38,7%) en el Grupo 2. No hubo diferencias en el strain longitudinal apical en reposo entre ambos grupos. Durante el apremio, los pacientes del Grupo1 evidenciaron mejor motilidad parietal visual y una RC más alta (p < 0,001). La RC y los cambios del strain longitudinal apical presentaron una correlación positiva (coeficiente r de Pearson = 0,89, p < 0,0001). En el seguimiento hubo 24 eventos mayores. Los pacientes del Grupo1 tuvieron una mejor supervivencia libre de eventos (p<0,01) y el strain longitudinal apical demostró ser un predictor independiente de evento, mejor que el análisis de motilidad parietal (p = 0,002 vs p = 0,1), en el análisis de regresión logística. Conclusiones: El strain longitudinal apical tiene muy buena correlación con: la reserva de velocidad del flujo coronario y se asocia mejor con el pronóstico a largo plazo. El strain longitudinal apical anormal durante el eco dipiridamol predijo un peor resultado, independientemente del análisis visual de la motilidad parietal.

ABSTRACT Background: Regional apical longitudinal strain can corroborate the diagnosis of regional wall motion abnormalities on a quantitative basis, but data on long-term prognostic value are lacking. Objectives: To evaluate the physiological correlate and the prognostic value of apical longitudinal strain versus wall motility during dipyridamole stress echocardiography. Methods: Retrospective study, which included 150 patients referred for dipyridamole stress echocardiography. Apical longitudinal strain, anterior descending artery coronary reserve, and visual analysis of wall motility were evaluated. Patients were divided into two groups. Group 1: patients with normal apical longitudinal strain, and Group 2: abnormal strain. Follow-up was carried out for 36 ± 9.3 months. Major event was defined as: death, myocardial infarction, revascularization and hospitalization for cardiac causes. Results. Eighty-seven patients (61.3%) in Group 1 and 55 (38.7%) patients in Group 2 were included (8 patients were excluded due to a suboptimal ultrasound window). There were no differences in apical longitudinal strain at rest between the groups. During the stress, Group 1 patients showed better visual wall motility and a higher coronary reserve (p < 0.001). The coronary reserve showed a linear correlation with the changes in the apical longitudinal strain (Pearson's correlation coefficient 0.89, p < 0.0001). At follow-up, there were 24 major events. Group 1 patients had better event-free survival (p < 0.01) and apical longitudinal strain proved to be a better independent event predictor than wall motion analysis (p = 0.002 vs p = 0.1) in logistic regression analysis. Conclusions: Apical longitudinal strain has a very good correlation with physiological standards -coronary flow velocity reserve- and its association with long-term prognosis is better. Abnormal apical longitudinal strain during dipyridamole stress echocardiography predicted a worse outcome, regardless of visual wall motion analysis.

Comparison of myocardial perfusion evaluation with single versus dual-energy CT and effect of beam-hardening artifacts.

RATIONALE AND OBJECTIVES: We sought to explore the feasibility and diagnostic performance of dual-energy computed tomography (DECT) versus single-energy computed tomography (SECT) for the evaluation of myocardial perfusion in patients with intermediate to high likelihood of coronary artery disease. MATERIALS AND METHODS: The present prospective study involved patients with known or suspected coronary artery disease referred for myocardial perfusion imaging by single-photon emission computed tomography. Forty patients were included in the study protocol and scanned using DECT imaging (n = 20) or SECT imaging (n = 20). The same pharmacologic stress was used for DECT, SECT, and single-photon emission computed tomography scans. RESULTS: A total of 1360 left ventricular segments were evaluated by DECT and SECT. The contrast-to-noise ratio was similar between groups (DECT 8.8 ± 2.9 vs. SECT 7.7 ± 4.2; P = .22). The diagnostic performance of DECT was greater than that of SECT in identifying perfusion defects (area under the receiver operating characteristic curve of DECT 0.90 [0.86-0.94] vs SECT 0.80 [0.76-0.84]; P = .0004) and remained unaffected when including only segments affected by beam-hardening artifacts (area under the receiver operating characteristic curve = DECT 0.90 [0.84-0.96) vs. SECT 0.77 [0.69-0.84]; P = .007). CONCLUSIONS: Our results suggest that myocardial perfusion by DECT imaging is feasible and might have improved diagnostic performance compared to SECT imaging for the assessment of myocardial CT perfusion. Furthermore, the diagnostic performance of DECT remained unaffected by the presence of beam-hardening artifacts.

Platelet antiaggregants in stroke prevention.

Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.